Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib?

Alessandra Tedeschi; Luca Laurenti; Alberto Fresa

doi:10.1182/bloodadvances.2021004824

Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib?

Alessandra Tedeschi, Luca Laurenti, Alberto Fresa

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

n/a

Lingua originale	English
pagine (da-a)	N/A-N/A
Rivista	Blood advances
DOI	https://doi.org/10.1182/bloodadvances.2021004824
Stato di pubblicazione	Pubblicato - 2021

Keywords

chronic lymphocytic leukaemia

Accesso al documento

10.1182/bloodadvances.2021004824

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{92d3f44ce00f4f76968067b11f569392,

title = "Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib?",

abstract = "n/a",

keywords = "chronic lymphocytic leukaemia, chronic lymphocytic leukaemia",

author = "Alessandra Tedeschi and Luca Laurenti and Alberto Fresa",

year = "2021",

doi = "10.1182/bloodadvances.2021004824",

language = "English",

pages = "N/A--N/A",

journal = "Blood advances",